NHS

News

AbbVie's ovarian cancer drug Elahere gets NHS green light

AbbVie's Elahere has become the first new NHS therapy in more than 20 years for resistant ovarian cancer, providing an alternative to chemotherapy.

News

DHSC lauds benefits of single patient record ahead of debate

The NHS digital single patient record (SPR) could result in 20,000 fewer A&E visits in England per year and save £20m a year, says the UK government.

News

Pharmacy First prescribing expanded to ease GP pressure

From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under the Pharmacy First programme.

News

Review advises against broad NHS prostate cancer screening

The UK's National Screening Committee has concluded that the harms of widespread prostate cancer screening would outweigh its benefits.

News

NICE changes stance on Genmab's cervical cancer drug

After saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement authority NICE has had a change of heart.

News

Doctors dismayed by report of NHS AI proposal

The British Medical Association has branded a leaked proposal to rein back NHS recruitment and use more AI to compensate a "massive gamble."

AbbVie's ovarian cancer drug Elahere gets NHS green light

DHSC lauds benefits of single patient record ahead of debate

Pharmacy First prescribing expanded to ease GP pressure

Review advises against broad NHS prostate cancer screening

NICE changes stance on Genmab's cervical cancer drug

Doctors dismayed by report of NHS AI proposal

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

NHS

Editor's Picks